Worldwide, ∼170 million people are thought to be chronically infected with HCV. These patients can develop serious long-term complications. Therapy for hepatitis C has progressed rapidly in the past few years; here, Donald Jensen and Noura Dabbouseh discuss the latest advances.
- Noura M. Dabbouseh
- Donald M. Jensen